282 related articles for article (PubMed ID: 19161413)
1. Interleukin-2 in the development and control of inflammatory disease.
Hoyer KK; Dooms H; Barron L; Abbas AK
Immunol Rev; 2008 Dec; 226():19-28. PubMed ID: 19161413
[TBL] [Abstract][Full Text] [Related]
2. T-cell fate and function: PKC-theta and beyond.
Marsland BJ; Kopf M
Trends Immunol; 2008 Apr; 29(4):179-85. PubMed ID: 18328786
[TBL] [Abstract][Full Text] [Related]
3. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
[TBL] [Abstract][Full Text] [Related]
4. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
7. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses.
Monteleone G; Pallone F; MacDonald TT
Trends Immunol; 2008 Jun; 29(6):290-4. PubMed ID: 18440864
[TBL] [Abstract][Full Text] [Related]
9. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
10. Effector and suppressor T cells in celiac disease.
Mazzarella G
World J Gastroenterol; 2015 Jun; 21(24):7349-56. PubMed ID: 26139981
[TBL] [Abstract][Full Text] [Related]
11. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
13. TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells.
Mittag D; Varese N; Scholzen A; Mansell A; Barker G; Rice G; Rolland JM; O'Hehir RE
Eur J Immunol; 2013 Mar; 43(3):723-33. PubMed ID: 23238878
[TBL] [Abstract][Full Text] [Related]
14. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
[TBL] [Abstract][Full Text] [Related]
15. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V
J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264
[TBL] [Abstract][Full Text] [Related]
17. Influence of a mutation in IFN-γ receptor 2 (IFNGR2) in human cells on the generation of Th17 cells in memory T cells.
Holzer U; Reinhardt K; Lang P; Handgretinger R; Fischer N
Hum Immunol; 2013 Jun; 74(6):693-700. PubMed ID: 23459074
[TBL] [Abstract][Full Text] [Related]
18. IL-23/IL-17 biology and therapeutic considerations.
Dong C
J Immunotoxicol; 2008 Jan; 5(1):43-6. PubMed ID: 18382857
[TBL] [Abstract][Full Text] [Related]
19. Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome.
Karakantza M; Theodorou GL; Meimaris N; Mouzaki A; John E; Andonopoulos AP; Maniatis A
Ann Hematol; 2004 Nov; 83(11):704-11. PubMed ID: 15300407
[TBL] [Abstract][Full Text] [Related]
20. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
